Internal Medicine · San Francisco, CA
NPI
1487660635
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1001 Potrero Ave, Bldg 30 Rm 3300
San Francisco, CA, 94110
Phone (415) 206-8189
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
190 services
Medicare patients, 2024
55
Average age 72
Drug cost, 2024
$2.1M
1,265 prescriptions
Company payments, 2025
$153
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan D Graf was code 99233 (hospital e&m - subsequent), 88 times for 28 patients. In total Jonathan D Graf billed 190 services in 8 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 88 | 28 | $105.21 | $9,258 |
| 99232 Hospital E&M - Subsequent | Facility | 40 | 20 | $70.26 | $2,810 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $153.97 | $3,695 |
| 99238 Hospital Discharge Management | Facility | 17 | 17 | $73.60 | $1,251 |
| 99222 Hospital E&M - Initial | Facility | 12 | 11 | $116.28 | $1,395 |
By year: 2022 $13K for 153 services; 2023 $21K for 239 services; 2024 $19K for 190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan D Graf prescribed most often to Medicare patients was Prednisone, with 233 prescriptions and refills. In total Jonathan D Graf wrote 1,265 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 233 | 451 | 59 | $1,659 |
| Methotrexate Methotrexate Sodium | 162 | 284 | 29 | $5,928 |
| Hydroxychloroquine Sulfate Generic | 81 | 202 | 24 | $3,069 |
| Sulfasalazine Generic | 75 | 164 | 18 | $3,074 |
| Cimzia (2 Pack) Certolizumab Pegol | 70 | 95 | Under 11 | $569K |
| Alendronate Sodium Generic | 58 | 156 | 17 | $382 |
| Humira Pen Adalimumab | 58 | 59 | Under 11 | $376K |
| Enbrel Sureclick Etanercept | 48 | 52 | Under 11 | $347K |
| Leflunomide Generic | 45 | 96 | Under 11 | $2,204 |
| Meloxicam Generic | 31 | 57 | 11 | $130 |
| Rasuvo Methotrexate/Pf | 25 | 32 | Under 11 | $17K |
| Enbrel Etanercept | 24 | 24 | Under 11 | $175K |
| Orencia Abatacept | 22 | 27 | Under 11 | $146K |
| Atorvastatin Calcium Generic | 21 | 55 | Under 11 | $45.03 |
| Rinvoq Upadacitinib | 19 | 25 | Under 11 | $148K |
Brand drugs: - claims; generic drugs: 828 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan D Graf $153 ($153 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Biotech, Inc. with $99.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.